Nanoparticulate drug delivery: perspectives on the transition from laboratory to market
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Oxford [u.a.]
Woodhead Pub.
2012
|
Ausgabe: | 1. publ. |
Schriftenreihe: | Woodhead publishing series in biomedicine
17 |
Schlagworte: | |
Beschreibung: | Includes bibliographical references and index |
Beschreibung: | xiv, 229 S. iIll., graph. Darst. 25 cm |
ISBN: | 9781907568985 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV041601191 | ||
003 | DE-604 | ||
005 | 20140221 | ||
007 | t | ||
008 | 140130s2012 ad|| |||| 00||| eng d | ||
015 | |a GBB271103 |2 dnb | ||
020 | |a 9781907568985 |c hbk. |9 978-1-907568-98-5 | ||
035 | |a (OCoLC)873423608 | ||
035 | |a (DE-599)BVBBV041601191 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-29 | ||
100 | 1 | |a Patravale, Vandana |e Verfasser |4 aut | |
245 | 1 | 0 | |a Nanoparticulate drug delivery |b perspectives on the transition from laboratory to market |c Vandana Patravale, Prajakta Dandekar and Ratnesh Jain |
250 | |a 1. publ. | ||
264 | 1 | |a Oxford [u.a.] |b Woodhead Pub. |c 2012 | |
300 | |a xiv, 229 S. |b iIll., graph. Darst. |c 25 cm | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Woodhead publishing series in biomedicine |v 17 | |
500 | |a Includes bibliographical references and index | ||
650 | 4 | |a Drug delivery systems | |
650 | 4 | |a Nanoparticles | |
650 | 4 | |a Drug Delivery Systems | |
650 | 4 | |a Economics, Pharmaceutical | |
650 | 4 | |a Marketing of Health Services | |
650 | 7 | |a Drug delivery systems |2 fast | |
650 | 7 | |a Nanoparticles |2 fast | |
700 | 1 | |a Dandekar, Prajakta |e Verfasser |4 aut | |
700 | 1 | |a Jain, Ratnesh |e Verfasser |4 aut | |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-1-908818-19-5 |
830 | 0 | |a Woodhead publishing series in biomedicine |v 17 |w (DE-604)BV040675553 |9 17 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-027042793 |
Datensatz im Suchindex
_version_ | 1804151794883887104 |
---|---|
any_adam_object | |
author | Patravale, Vandana Dandekar, Prajakta Jain, Ratnesh |
author_facet | Patravale, Vandana Dandekar, Prajakta Jain, Ratnesh |
author_role | aut aut aut |
author_sort | Patravale, Vandana |
author_variant | v p vp p d pd r j rj |
building | Verbundindex |
bvnumber | BV041601191 |
ctrlnum | (OCoLC)873423608 (DE-599)BVBBV041601191 |
edition | 1. publ. |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01538nam a2200433 cb4500</leader><controlfield tag="001">BV041601191</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20140221 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">140130s2012 ad|| |||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">GBB271103</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781907568985</subfield><subfield code="c">hbk.</subfield><subfield code="9">978-1-907568-98-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)873423608</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV041601191</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Patravale, Vandana</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nanoparticulate drug delivery</subfield><subfield code="b">perspectives on the transition from laboratory to market</subfield><subfield code="c">Vandana Patravale, Prajakta Dandekar and Ratnesh Jain</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. publ.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford [u.a.]</subfield><subfield code="b">Woodhead Pub.</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xiv, 229 S.</subfield><subfield code="b">iIll., graph. Darst.</subfield><subfield code="c">25 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Woodhead publishing series in biomedicine</subfield><subfield code="v">17</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug delivery systems</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanoparticles</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Delivery Systems</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Economics, Pharmaceutical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Marketing of Health Services</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug delivery systems</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanoparticles</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dandekar, Prajakta</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jain, Ratnesh</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-1-908818-19-5</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Woodhead publishing series in biomedicine</subfield><subfield code="v">17</subfield><subfield code="w">(DE-604)BV040675553</subfield><subfield code="9">17</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027042793</subfield></datafield></record></collection> |
id | DE-604.BV041601191 |
illustrated | Illustrated |
indexdate | 2024-07-10T01:00:29Z |
institution | BVB |
isbn | 9781907568985 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027042793 |
oclc_num | 873423608 |
open_access_boolean | |
owner | DE-29 |
owner_facet | DE-29 |
physical | xiv, 229 S. iIll., graph. Darst. 25 cm |
publishDate | 2012 |
publishDateSearch | 2012 |
publishDateSort | 2012 |
publisher | Woodhead Pub. |
record_format | marc |
series | Woodhead publishing series in biomedicine |
series2 | Woodhead publishing series in biomedicine |
spelling | Patravale, Vandana Verfasser aut Nanoparticulate drug delivery perspectives on the transition from laboratory to market Vandana Patravale, Prajakta Dandekar and Ratnesh Jain 1. publ. Oxford [u.a.] Woodhead Pub. 2012 xiv, 229 S. iIll., graph. Darst. 25 cm txt rdacontent n rdamedia nc rdacarrier Woodhead publishing series in biomedicine 17 Includes bibliographical references and index Drug delivery systems Nanoparticles Drug Delivery Systems Economics, Pharmaceutical Marketing of Health Services Drug delivery systems fast Nanoparticles fast Dandekar, Prajakta Verfasser aut Jain, Ratnesh Verfasser aut Erscheint auch als Online-Ausgabe 978-1-908818-19-5 Woodhead publishing series in biomedicine 17 (DE-604)BV040675553 17 |
spellingShingle | Patravale, Vandana Dandekar, Prajakta Jain, Ratnesh Nanoparticulate drug delivery perspectives on the transition from laboratory to market Woodhead publishing series in biomedicine Drug delivery systems Nanoparticles Drug Delivery Systems Economics, Pharmaceutical Marketing of Health Services Drug delivery systems fast Nanoparticles fast |
title | Nanoparticulate drug delivery perspectives on the transition from laboratory to market |
title_auth | Nanoparticulate drug delivery perspectives on the transition from laboratory to market |
title_exact_search | Nanoparticulate drug delivery perspectives on the transition from laboratory to market |
title_full | Nanoparticulate drug delivery perspectives on the transition from laboratory to market Vandana Patravale, Prajakta Dandekar and Ratnesh Jain |
title_fullStr | Nanoparticulate drug delivery perspectives on the transition from laboratory to market Vandana Patravale, Prajakta Dandekar and Ratnesh Jain |
title_full_unstemmed | Nanoparticulate drug delivery perspectives on the transition from laboratory to market Vandana Patravale, Prajakta Dandekar and Ratnesh Jain |
title_short | Nanoparticulate drug delivery |
title_sort | nanoparticulate drug delivery perspectives on the transition from laboratory to market |
title_sub | perspectives on the transition from laboratory to market |
topic | Drug delivery systems Nanoparticles Drug Delivery Systems Economics, Pharmaceutical Marketing of Health Services Drug delivery systems fast Nanoparticles fast |
topic_facet | Drug delivery systems Nanoparticles Drug Delivery Systems Economics, Pharmaceutical Marketing of Health Services |
volume_link | (DE-604)BV040675553 |
work_keys_str_mv | AT patravalevandana nanoparticulatedrugdeliveryperspectivesonthetransitionfromlaboratorytomarket AT dandekarprajakta nanoparticulatedrugdeliveryperspectivesonthetransitionfromlaboratorytomarket AT jainratnesh nanoparticulatedrugdeliveryperspectivesonthetransitionfromlaboratorytomarket |